FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes compounds of the formula (I) where R5 is a linear or branched C10-C24-alkyl residue that can has also 1-3 double and/or triple bonds; A means a simple bond or one of groups of the formulas (II) -CH2-CH2-CH2-O- (II), (III) -CH2-CH2-O- (III), (IV) , (V) , (VI) being R7 means linear C1-C4--alkyl group and groups (II)-(VI) are oriented so that oxygen atom is bound with phosphorus atom of compound (I); X means oxygen or sulfur atom; A′- means linear or branched C2-C10--alkyl residue; R6 is Y-(R8R9R10) where R8,R9,R10 are similar or distinct and they mean independently each of other hydrogen, linear, branched or cyclic C1-C6-alkyl residue, or two residues can form a ring; Y means P, As, Sb or B. Method of synthesis involves interaction of compound of the formula (VII) R5-X-A-H (VII) where values for R5, X and A are indicated above with phosphorus oxychloride in solvent medium or without its. The synthesized substance is subjected for interaction with a compound of the formula (VIII): HO-A′-R6 where values A′ and R6 are indicated above followed by hydrolysis. Invention proposes also a pharmaceutical composition showing antitumor and/or antileishmaniosis effect that contains at least a single compound of the formula (I) as an active component and taken at effective amount, and also to a method of preparing a pharmaceutical composition showing antitumor and/or antileishmaniosis effect that involves mixing one or more compounds of the formula (I) with addition of one or more a pharmaceutically acceptable special additions followed by processing the obtained mixture to the usual medicinal forms. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 6 cl, 29 ex
Title |
Year |
Author |
Number |
PHOSPHOLIPID DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND A METHOD OF ITS PREPARING |
1993 |
- Gerkhard Nessner[De]
- Bernkhard Kucher[De]
- Jurgen Ehngel'[De]
- Vol'Fgang Shumakher[De]
- Jurij Shtekar[De]
- Peter Khil'Gard[De]
|
RU2108336C1 |
PHOSPHORYLATED SERINES |
1989 |
- Khans Brakhvitts[De]
- Rajnkhild Shenfel'D[De]
- Peter Langen[De]
- Fridrikh Paltauf[At]
- Albin Khermetter[At]
|
RU2057133C1 |
ANTAGONISTS OF LUTEINIZING HORMONE RELEASING-FACTOR (VARIANTS), METHOD OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD OF MEDICINAL PREPARATIONS PREPARING |
1996 |
- Bekers Tomas
- Bernd Mikhaehl'
- Klenner Tomas
- Kucher Berngard
- Sharpent'E Parisil-Mari
- Ehmig Peter-Paul'
|
RU2163910C2 |
ANALOGS OF LHRH ANTAGONISTS AND METHODS OF THEIR SYNTHESIS |
1991 |
|
RU2123499C1 |
DERIVATIVES OF N-PHENYL-2-PYRIMIDINEAMINE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION BASED ON SAID SHOWING ANTITUMOR ACTIVITY |
1993 |
|
RU2125992C1 |
1,2,4-SUBSTITUTED PIPERIDINES AND A METHOD OF THEIR SYNTHESIS, INTERMEDIUM COMPOUNDS OF PIPERIDONE AND A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON NEW COMPOUNDS |
1992 |
- Val'Ter Shilling
- Sil'Vio Ofner
- Sim Dzh.Veenstra
|
RU2114829C1 |
METHOD FOR PRODUCING OXAZAPHOSPHORINO-4-THIOALKANSULFOACID OR NEUTRAL SALTS THEREOF |
0 |
- Gerkhard Sheffler
- Ulf Nimejer
- Norbert Brok
- Jerg Pol
|
SU1318167A3 |
DERIVATIVES OF CYCLOALKANOINDOLE AND AZAINDOLE, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, DERIVATIVES OF CARBOXYLIC ACID AS PARENT COMPOUNDS AND PHARMACEUTICAL COMPOSITION INHIBITING RELEASE OF LIPOPROTEINS ASSOCIATED WITH APOLIPOPROTEIN B-100 |
1995 |
- Ul'Rikh Mjuller
- Richard Konnell
- Zigfrid Gol'Dmann
- Rudi Grjuttsmann
- Martin Bojk
- Khil'Mar Bishoff
- Dirk Dentser
- Anke Domdej-Bette
- Shtefan Vol'Fejl'
|
RU2157803C2 |
|
0 |
|
SU446969A1 |
IMMUNOFYLLINE-SPECIFIC LIGANDS AS ANTIASTHMATIC AND IMMUNO-DEPRESSANT AGENTS AND METHOD OF THEIR SYNTHESIS, PHARMACEUTICALLY READY FORM, MEDICINAL AGENT AND METHOD OF ITS PREPARING |
1997 |
- Bang Khol'Ger
- Bruneh Kaj
- Kvinkert Gerkhard
- Kucher Berngard
- Rajkhert Ditmar
- Shajble Khans-Gjunter
|
RU2172743C2 |